Literature DB >> 17645221

Screening Evaluation System--Europe (SESy_Europe) met skin cancer screening.

Vasiliki Karampoiki, Francisco Javier Rivas Flores, Hilal Altinoz, Marzanna Chojnacka, Irini Karentzou, Mario Dambrosio, Camelia Colichi, Tamara Oxiuzova, Eleni Kanavoura, Berta Adelaide Maia da Silva Alves de Sousa, Diana Ivanova, Jacopo Mauri, Georgios Alexiou, Davide Mauri, Konstantinos Kamposioras, Angeliki Maragkaki, Christina Peponi.   

Abstract

Skin tumors are the most frequent malignancies in the white population worldwide and have reached the proportion of an epidemic disease. Since non-melanocytic skin cancers can be cured when timely detected, given that still malignant melanoma may have good prognosis if early diagnosed, and considering the key role of primary care in cancer screening advising and implementation, the international PACMeR study group (trial_01.3) adjourned SESy_Europe database in a version comprehensive of skin-malignancies screening indexing. The novel database provides standardized pre-codified translations of 2,331 parameters in eight languages (English, French, German, Greek, Italian, Romanian, Spanish and Turkish) and records the time elapsed from last skin examination, cause and frequency of skins examinations and stratifies skin cancer risk patterns by a systematic registering of risk factors. A comprehensive indexing of skin cancer screening practices among European countries may in fact turn helpful in programming future health policy and tailoring interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17645221     DOI: 10.21101/cejph.a3411

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  23 in total

Review 1.  Methods for analyzing health care utilization and costs.

Authors:  P Diehr; D Yanez; A Ash; M Hornbrook; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

3.  Obesity is a chronic, relapsing neurochemical disease.

Authors:  G A Bray
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01

Review 4.  KORA--a research platform for population based health research.

Authors:  R Holle; M Happich; H Löwel; H E Wichmann
Journal:  Gesundheitswesen       Date:  2005-08

5.  Obesity--a risk factor or a RISK factor for myocardial infarction?

Authors:  G Heusch
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

6.  Use of medical doctors, physical therapists, and alternative practitioners by obese adults: does body weight dissatisfaction mediate extant associations?

Authors:  Thomas von Lengerke; Jürgen John
Journal:  J Psychosom Res       Date:  2006-10       Impact factor: 3.006

Review 7.  Long-term pharmacotherapy for obesity and overweight.

Authors:  R Padwal; S K Li; D C W Lau
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 8.  Outpatient management of obesity: a primary care perspective.

Authors:  James O Hill; Holly Wyatt
Journal:  Obes Res       Date:  2002-12

9.  A method for estimating baseline health care costs.

Authors:  S F Hurley; L M Bond; J B Carlin; D B Evans; J M Kaldor
Journal:  J Epidemiol Community Health       Date:  1995-10       Impact factor: 3.710

10.  Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life.

Authors:  Martin Fortin; Catherine Hudon; Marie-France Dubois; José Almirall; Lise Lapointe; Hassan Soubhi
Journal:  Health Qual Life Outcomes       Date:  2005-11-23       Impact factor: 3.186

View more
  1 in total

1.  Screening practice and misplaced priorities.

Authors:  Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Ivan Cortinovis; Vassiliki Karampoiki; Evridiki Loukidou; Paraskevi Alevizaki; Konstantinos Kamposioras; Georgios Kouris; Parthenopi Alexandropoulou; Lamprini Tsali; Charalampos Panou; Athanasios Stamatelopoulos; Velisarios Lakiotis; Anastasia Spiliopoulou; Aikaterini Terzoudi; Aliki Ioakimidou; Ioanna Karathanasi; Magdalini Bristianou; Giovanni Casazza; Nicholas Pavlidis
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.